Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
4.570
+0.040 (0.88%)
At close: Mar 9, 2026, 4:00 PM EDT
4.660
+0.090 (1.97%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Atossa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 39 | 119 | 110 | 67 | 203 | 37 | |
| Market Cap Growth | -62.77% | 7.71% | 64.77% | -66.97% | 445.88% | 158.90% | |
| Enterprise Value | -12 | 44 | 17 | -50 | 63 | 29 | |
| Last Close Price | 4.57 | 14.16 | 13.20 | 7.93 | 24.00 | 14.25 | |
| PB Ratio | 0.79 | 1.66 | 1.21 | 0.57 | 1.47 | 1.37 | |
| P/TBV Ratio | 0.79 | 1.66 | 1.21 | 0.57 | 1.47 | 1.40 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.00 | |
| Net Debt / Equity Ratio | -1.04 | -0.99 | -0.97 | -0.94 | -0.99 | -1.45 | |
| Net Debt / EBITDA Ratio | 1.58 | 2.58 | 2.82 | 4.01 | 6.65 | 2.72 | |
| Net Debt / FCF Ratio | 1.97 | 3.38 | 4.22 | 5.34 | 8.28 | 3.41 | |
| Quick Ratio | 6.30 | 14.31 | 16.90 | 20.05 | 43.97 | 2.57 | |
| Current Ratio | 6.77 | 14.99 | 17.61 | 21.23 | 45.18 | 2.73 | |
| Return on Equity (ROE) | -48.89% | -31.39% | -28.80% | -21.05% | -24.93% | -88.42% | |
| Return on Assets (ROA) | -29.87% | -19.99% | -17.84% | -13.07% | -13.93% | -31.85% | |
| Return on Capital Employed (ROCE) | -66.00% | -38.60% | -34.50% | -23.50% | -14.90% | -53.80% | |
| Earnings Yield | -76.69% | -21.47% | -27.29% | -40.29% | -10.17% | -48.03% | |
| FCF Yield | -66.80% | -17.72% | -19.00% | -31.06% | -8.13% | -31.20% | |
| Buyback Yield / Dilution | -2.39% | 0.18% | 0.43% | -8.27% | -934.13% | -33.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.